Press Releases
-
2023/11/09 | Press Releases
Turkish Ambassador to China Visits SINOVAC in Beijing
-
2023/11/01 | Press Releases
SINOVAC Launches Its First Overseas Jointly Invested Vaccine Production Plant in Türkiye
Turkish President Recep Tayyip Erdoğan Attends the Inauguration Ceremony for KeyVac on October 31November 1, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company"
-
2023/10/20 | Press Releases
SINOVAC's Vital Role in the Belt and Road Initiative: A Lifeline in the Fight Against Infectious Diseases
October 20, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today shared its acco
-
2023/10/19 | Press Releases
CPHI Barcelona 2023: SINOVAC Showcases Comprehensive Product Portfolio
Pioneering Antibody Products and WHO Approved Vaccines Will Advance Prevention and Treatment of Infectious Diseases October 19, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the
-
2023/10/18 | Press Releases
SINOVAC Chairman Meets with Chilean President to Foster Bilateral Cooperation
The Company engages in dialogue exploring Chinese investment opportunities in Chile and greater global vaccine accessibility in the interest of human health October 17, 2023, Beijing, China – Sinovac
-
2023/09/21 | Press Releases
SINOVAC Begins Phase I Trials of Bivalent Enterovirus Vaccine
Vaccine is First to Target Both EV71 and CA16 Viruses, Boosting HFMD PreventionSeptember 21, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA),
-
2023/09/11 | Press Releases
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
Clinical trials will advance treatment of COVID-19 infection. September 11, 2023, Beijing, China – Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceuti
-
2023/09/05 | Press Releases
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
Board of Directors Unanimously Recommends Sinovac Shareholders NOT Tender Shares for purchase pursuant to the Offer to Purchase BEIJING, China, September 5, 2023 /Business Wire/ -- Sinovac Biotech Ltd
-
2023/08/29 | Press Releases
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
BEIJING, China, August 29, 2023 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, confirmed today that it i
-
2023/08/28 | Press Releases
Sinovac Announces Change of Legal Representative of Sinovac Beijing
BEIJING, China, August 28 2023 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that the C
-
2023/08/15 | Press Releases
SINOVAC Reports Unaudited First Half of 2023 Financial Results
BEIJING, China, August 15, 2023 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaud
-
2023/07/28 | Press Releases
SINOVAC Expands Strategic Partnership with Bio Farma, Bolstering Indonesia's Vaccine Supply
-
2023/06/30 | Press Releases
SINOVAC's Healive® Maintains Three-Decade-Long Immunity in 15-Year Study
June 30, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced promisin
-
2023/06/05 | Press Releases
SINOVAC Named BogotáBio Exclusive Partner, Fueling New Vaccine Advances in Colombia
June 5, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced it has be
-
2023/05/29 | Press Releases
SINOVAC Addresses COVID-19 Mutations with Broad-Spectrum Neutralizing Antibody Products: SA55 Injection and Nasal Spray Approved for Clinical Trial in China
May 29, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced its Anti-COVID-
-
2023/05/01 | Press Releases
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, has filed its 2022 annual report on Form 20-F with the U
-
2023/04/10 | Press Releases
SINOVAC Launches New Influenza Vaccine Production Facility
Plant will expand worldwide flu vaccine capacity while setting leading standards for quality and sustainabilityApril 10, 2023, Beijing, China – Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider o
-
2023/02/08 | Press Releases
SINOVAC's Hepatitis A Vaccine Healive® Approved in Kyrgyzstan
-
2023/02/03 | Press Releases
SINOVAC Provides Vaccines to Step Up Preventative Healthcare for Children in Turkey
-
2023/01/12 | Press Releases
SINOVAC's Hepatitis A Vaccine Healive® Approved in Lebanon
-
2022/12/29 | Press Releases
SINOVAC Reports Unaudited First Half of 2022 Financial Results
-
2022/12/21 | Press Releases
SINOVAC's COVID-19 Vaccine Obtains the Official Pharmaceutical Product Registration in Hong Kong
-
2022/12/06 | Press Releases
SINOVAC's Hepatitis A Vaccine Healive® Launched in Indonesia
-
2022/11/29 | Press Releases
SINOVAC Quadrivalent Influenza Vaccine Authorized for Commercialization in the Dominican Republic
November 29, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its quadriv
-
2022/11/22 | Press Releases
WHO Extended the Use of SINOVAC COVID-19 Vaccine under EUL to Individuals Aged 3 Years and Above
-
2022/11/18 | Press Releases
SINOVAC's EV71 Vaccine Inlive® Approved in Indonesia
-
2022/11/09 | Press Releases
SINOVAC Donates 100,000 Doses of Hepatitis A Vaccines to Pakistan
-
2022/11/04 | Press Releases
SINOVAC Varicella Vaccine Prequalified by WHO
-
2022/10/28 | Press Releases
SINOVAC to Showcase Products at CPHI Frankfurt
-
2022/10/21 | Press Releases
SINOVAC-Sponsored Automated Complex for Vaccine Storage and Distribution is Delivered to the Egyptian
-
2022/10/21 | Press Releases
SINOVAC Joins Hands with UdeA to Boost Biomedicine R&D in Colombia
October 21, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that the Co
-
2022/09/16 | Press Releases
SINOVAC Quadrivalent Influenza Vaccine Is Authorized For Marketing Use in Bangladesh
-
2022/09/06 | Press Releases
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
-
2022/08/25 | Press Releases
SINOVAC COVID-19 Vaccine Approved for Use in Children 6 Months and Older in Chile
-
2022/08/20 | Press Releases
Sinovac Beijing's QC Laboratory Accredited By CNAS
-
2022/08/15 | Press Releases
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
-
2022/07/19 | Press Releases
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
July 19, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that a phase III cli
-
2022/07/14 | Press Releases
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
July 14, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID-19 va
-
2022/06/25 | Press Releases
SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
-
2022/06/02 | Press Releases
SINOVAC Polio Vaccine Prequalified by WHO
-
2022/05/26 | Press Releases
Chilean Report Confirms CoronaVac Safety for Pediatric and Adolescent Population
On May 20, 2022, the Public Health Institute of Chile (ISP) released the fourth statistical report "AEFIs after the administration of SARS-CoV-2 vaccines in Chile in the pediatric and adolescent
-
2022/04/30 | Press Releases
SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F
-
2022/04/26 | Press Releases
China NMPA approved SINOVAC Omicron-specific vaccine for clinical trial
-
2022/04/17 | Press Releases
SINOVAC Omicron-specific vaccine approved for clinical trial in Hong Kong
-
2022/03/23 | Press Releases
Three doses of SINOVAC COVID-19 vaccine well prevent the worst outcomes during HK Omicron wave
-
2022/02/25 | Press Releases
CUHK and SINOVAC Biotech (Hong Kong) Limited strategic collaboration framework agreement signing ceremony
-
2022/02/18 | Press Releases
CUHK and SINOVAC join in hands in building P3 laboratory
-
2021/12/31 | Press Releases
SINOVAC Reports Unaudited First Half of 2021 Financial Results
BEIJING--Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results
-
2021/12/29 | Press Releases
SINOVAC CoronaVac® Shows Good Safety in Pregnant and Postpartum Women
SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, collaborating with IQVIA Brazil published an article on December 17 titled “
-
2021/12/29 | Press Releases
South Africa Phase III Clinical Study Shows SINOVAC CoronaVac® Safe for Children as Young as 6 Months
Beijing, China, December 24, 2021 – SINOVAC Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced resu
-
2021/12/10 | Press Releases
Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment
Current SINOVAC Directors Elected Properly at the 2018 Annual General Meeting The Company's Rights Agreement is Valid under Antigua LawDecember 9, 2021 -- BEIJING--SINOVAC Biotech Ltd. (NASDAQ: SV
-
2021/11/29 | Press Releases
Instituto Butantan and SINOVAC will hold 'CoronaVac® Symposium' international event about efficacy and security of CoronaVac®
Instituto Butantan, in partnership with Sinovac Biotech, is pleased to announce CoronaVac® Symposium, an international online event that aims to promote and discuss the latest results of the efficacy
-
2021/11/08 | Press Releases
SINOVAC COVID-19 Vaccine Authorized for Commercial Sale in Myanmar
-
2021/10/26 | Press Releases
SINOVAC actively discusses COVID-19 Vaccine application and the industry development with other countries
-
2021/09/09 | Press Releases
SINOVAC Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Children and Adolescents
-
2021/08/10 | Press Releases
SINOVAC Announces Positive Data on Booster Shots of CoronaVac®, Induces Strong Immune Response in Adult and Elderly Populations
CoronaVac® generates good immune memory after second doseThird dose of vaccine significantly increased neutralizing antibody levels in adults and elderly populationFindings indicate a third dose of Co
-
2021/07/27 | Press Releases
SINOVAC Announces Positive Data on Booster Dose of CoronaVac®
CoronaVac® generates good immune memory after the second doseThird dose of CoronaVac® induces strong immune response No serious adverse reactions reportedAdverse reactions reported within 28 day after
-
2021/07/20 | Press Releases
SINOVAC's CoronaVac® Used on Child and Adolescent Population in China, Good Antibody Levels Observed After Three Months Following Vaccination
BEIJING, China, July 19, 2021 -- SINOVAC Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced CoronaV
-
2021/07/19 | Press Releases
SINOVAC Receives Approval on Sabin Strain Based Inactivated Polio Vaccine (sIPV) to Support Global Polio Endgame Strategy
SINOVAC Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced it received a drug registration approval
-
2021/07/18 | Press Releases
Clarification Statement
SINOVAC Biotech Ltd. ("SINOVAC") recently noticed a Portuguese-language press release with a statement that does not conform to the facts. This fraudulent statement ("Fraudulent Stateme
-
2021/07/13 | Press Releases
SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX
BEIJING, China, July 12, 2021 -- SINOVAC Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that it
-
2021/06/12 | Press Releases
SINOVAC’s EV71 vaccine Inlive® is approved for children aged from 6 to 71 months
-
2021/06/02 | Press Releases
World Health Organization Authorizes SINOVAC’s CoronaVac® for Emergency Use
-
2021/05/06 | Press Releases
EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated
-
2021/04/24 | Press Releases
Sinovac Reports Unaudited Fourth Quarter 2020 Financial Results and Files 2020 Annual Report on Form 20-F
BEIJING--Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2020 annual report on Form 20-F with the U.S. Securit
-
2021/04/03 | Press Releases
Summary of Clinical Trial Data of Sinovac’s COVID-19 Vaccine (CoronaVac®)
-
2021/04/02 | Press Releases
Sinovac Announced Buildup of Two Billion Annual Capacity of Its COVID-19 Vaccine
-
2021/02/22 | Press Releases
Sinovac Amends Shareholder Rights Plan
-
2021/02/08 | Press Releases
Sinovac Receives Conditional Marketing Authorization in China for its COVID-19 Vaccine
-
2021/02/05 | Press Releases
Sinovac Announces Phase III Results of Its COVID-19 Vaccine
-
2021/02/03 | Press Releases
Sinovac Files for Conditional Market Authorization of COVID-19 Vaccine in China
-
2021/01/31 | Press Releases
Clarification Statement
-
2021/01/28 | Press Releases
Statement
-
2020/12/09 | Press Releases
Sinovac Announces Product License for 23-Valent Pneumococcal Polysaccharide Vaccine
-
2020/12/07 | Press Releases
Sinovac Reports Unaudited Third Quarter 2020 Financial Results
-
2020/12/07 | Press Releases
Sinovac Secures Approximately $500 Million in Funding for COVID-19 Vaccine Development
-
2020/11/11 | Press Releases
Brazil's National Health Surveillance Agency Authorizes Resumption of the Phase III Clinical Trial of CoronaVac™
-
2020/11/10 | Press Releases
A Clarification of Interruption in Phase III trial On COVID-19 Vaccine
-
2020/10/13 | Press Releases
A Phase III Clinical Trial of the 5-Dose Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strain
-
2020/09/28 | Press Releases
Beijing Fourth Intermediate People’s Court Issues Judgement Against Sinobioway Medicine and Mr. Aihua Pan
-
2020/09/23 | Press Releases
Sinovac’s Coronavac™, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children
-
2020/09/22 | Press Releases
Sinovac Commences Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey
-
2020/09/09 | Press Releases
Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in Elderly Volunteers
-
2020/08/28 | Press Releases
Sinovac Reports Unaudited Second Quarter 2020 Financial Results
-
2020/08/25 | Press Releases
Sinovac Signs Agreement with Bio Farma Indonesia for COVID-19 Vaccine Cooperation
-
2020/07/06 | Press Releases
Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial
-
2020/06/30 | Press Releases
Sinovac Reports Unaudited First Quarter 2020 Financial Results
-
2020/06/24 | Press Releases
Sinovac Receives Approval from China for its Quadrivalent Influenza Vaccine
-
2020/06/13 | Press Releases
Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19
-
2020/06/11 | Press Releases
Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III
-
2020/05/22 | Press Releases
Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development
-
2020/05/18 | Press Releases
Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital
-
2020/05/06 | Press Releases
Sinovac Announces First Animal Study Results of Vaccine Against COVID-19 Published in SCIENCE
-
2020/04/30 | Press Releases
Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-F
-
2020/04/17 | Press Releases
Sinovac Announces Commencement of Phase I Human Clinical Trial for Vaccine Candidate Against COVID-19
-
2020/04/14 | Press Releases
Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19
-
2020/02/22 | Press Releases
Sinovac Amends Shareholder Rights Plan
-
2019/12/27 | Press Releases
Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children
-
2019/11/15 | Press Releases
Sinovac Reports Unaudited Third Quarter 2019 Financial Results
-
2019/08/15 | Press Releases
Sinovac Reports Unaudited Second Quarter 2019 Financial Results
-
2019/07/10 | Press Releases
Sinovac Reports Unaudited First Quarter 2019 Financial Results
-
2019/04/29 | Press Releases
Sinovac Reports Unaudited Second Half of 2018 Financial Results and Files 2018 Annual Report on Form 20-F
-
2019/04/16 | Press Releases
Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the JID
Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in The Journal of Infectious DiseasesThe Sinovac-developed sIPV demonstrates
-
2019/04/13 | Press Releases
Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares
-
2019/03/08 | Press Releases
Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares
-
2019/02/22 | Press Releases
Sinovac Determines Trigger Event Occurred Under Rights Agreement
-
2018/12/19 | Press Releases
Sinovac Comments on Antigua and Barbuda Court Decision Denying 1Globe Capital’s Claim; Current Board Was Validly Elected at Annual General Meeting
-
2018/12/13 | Press Releases
Haidian District People’s Court in Beijing Issues Injunction Order Restraining Aihua Pan from Using Business License and Corporate Seal of Sinovac Bei
-
2018/11/29 | Press Releases
Hong Kong High Court Issues Declaratory Orders and Permanent Injunctive Relief in Favor of Sinovac’s Senior Management
-
2018/11/08 | Press Releases
Sinovac Reports Unaudited First Half of 2018 Financial Results
-
2018/10/22 | Press Releases
Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing a Falsified Company Seal and Forged Board Member Signatures
-
2018/10/17 | Press Releases
U.S. District Court in Massachusetts Denies 1Globe’s Motion for Preliminary Injunction to Enjoin Sinovac’s Issuance of Shares
-
2018/10/16 | Press Releases
Sinovac Commences Legal Proceedings to Nullify Filings Bearing a Falsified Company Seal and Forged Board Member Signatures
-
2018/10/10 | Press Releases
Sinovac Comments on Unauthorized Use of Falsified Sinovac Hong Kong’s Company Seal and Subsidiary Board Member Signatures
-
2018/08/20 | Press Releases
SEC Concludes Investigation of Sinovac
-
2018/07/03 | Press Releases
Sinovac Raises $86.73 Million Through Private Placement Transaction
-
2018/06/26 | Press Releases
Sinovac Files Motion for Summary Judgment on Rights Agreement in Delaware Chancery Court
-
2018/06/11 | Press Releases
Sinovac Biotech Relaunches Company Website
-
2018/05/11 | Press Releases
Sinovac Files 2017 Annual Report on Form 20-F and Reports Unaudited Second Half, Audited Full Year 2017 Financial Results
-
2018/05/08 | Press Releases
Sinovac Forced to Temporarily Suspend Hepatitis A Vaccine Production Line Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing
-
2018/04/30 | Press Releases
Sinovac Forced to Plan to Destroy Bacterial Seeds intended for Pneumo Vaccine Production and Postpone Site Inspection
-
2018/04/30 | Press Releases
Sinovac Temporarily Blocks Access to Its Websites
-
2018/04/27 | Press Releases
Sinovac to Delay Filing of 2017 Annual Report on Form 20-F Following Actions Taken by the Minority Shareholder of Sinovac Beijing
-
2018/04/27 | Press Releases
Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction
-
2018/04/24 | Press Releases
Sinovac Resumes Production and Operation at Sinovac Beijing's Quality Assurance Department
-
2018/04/19 | Press Releases
Sinovac Announces Preliminary Results of Phase III Trial on sIPV
-
2018/04/18 | Press Releases
Sinovac Sets the Record Straight Regarding False Statements by Shandong Sinobioway Biomedicine Co., Ltd.
-
2018/03/27 | Press Releases
Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction
-
2018/03/15 | Press Releases
Sinovac Sets the Record Straight Regarding False Statements by Unauthorized Third Parties
-
2018/03/07 | Press Releases
Sinovac Amends Shareholder Rights Plan
-
2018/03/06 | Press Releases
Sinovac Announces Enhancement of Corporate Governance and Management of China Operating Entity
-
2018/03/06 | Press Releases
Sinovac Announces Re-Election of All Directors at Annual General Meeting
-
2018/02/07 | Press Releases
Sinovac Provides Update on Going Private Transaction
-
2018/02/07 | Press Releases
Sinovac Holds 2017 Annual General Meeting of Shareholders
-
2017/12/29 | Press Releases
Sinovac Schedules 2017 Annual Meeting of Shareholders
-
2017/12/23 | Press Releases
Sinovac Biotech Receives Positive Decision on its Hepatitis A Vaccine from World Health Organization
-
2017/12/01 | Press Releases
Sinovac Biotech Cures Nasdaq Filing Deficiency
-
2017/12/01 | Press Releases
Sinovac Reports Unaudited First Half of 2017 Financial Results
-
2017/11/30 | Press Releases
Sinovac Biotech Announces Update on Nasdaq Matters
-
2017/11/23 | Press Releases
Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results
-
2017/11/09 | Press Releases
Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel
-
2017/11/04 | Press Releases
Sinovac Biotech Announces Receipt of DelistingDetermination Letter fromNasdaq
-
2017/09/25 | Press Releases
Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against Chickenpox
-
2017/08/14 | Press Releases
Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F
-
2017/06/26 | Press Releases
Sinovac Biotech Ltd. Enters into Definitive Agreement for Going-Private Transaction
-
2017/05/17 | Press Releases
Sinovac Biotech Announces Receipt of NASDAQ Letter
-
2017/05/01 | Press Releases
Sinovac Reports Announces Filing Extension for 2016 Annual Report
-
2017/03/24 | Press Releases
Sinovac Amends Shareholder Rights Plan
-
2016/12/23 | Press Releases
Sinovac Responds to Recent Report
-
2016/11/28 | Press Releases
Sinovac Reports Unaudited Third Quarter 2016 Financial Results
-
2016/11/15 | Press Releases
Sinovac to Host Conference Call to Report Third Quarter 2016 Unaudited Financial Results
-
2016/11/07 | Press Releases
Sinovac Announces Results of 2016 Annual General Meeting of Shareholders
-
2016/10/19 | Press Releases
Sinovac Product Pipeline News
-
2016/09/30 | Press Releases
Sinovac Schedules 2016 Annual Meeting of Shareholders
-
2016/08/23 | Press Releases
Sinovac Reports Unaudited Second Quarter 2016 Financial Results
-
2016/08/15 | Press Releases
Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results
-
2016/05/27 | Press Releases
Sinovac Reports Unaudited First Quarter 2016 Financial Results
-
2016/05/20 | Press Releases
Sinovac to Host Conference Call to Report First Quarter of 2016 Unaudited Financial Results
-
2016/04/26 | Press Releases
Sinovac Files 2015 Annual Report on Form 20-F
-
2016/04/14 | Press Releases
Sinovac Special Committee Engages Financial and Legal Advisors
-
2016/04/05 | Press Releases
Sinovac Reports Unaudited Fourth Quarter and Full Year 2015 Financial Results
-
2016/04/02 | Press Releases
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2015 Unaudited Financial Results
-
2016/03/28 | Press Releases
Sinovac Adopts Shareholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights
-
2016/02/04 | Press Releases
Sinovac Announces Receipt of Competing Non-Binding “Going Private” Proposal
-
2016/02/01 | Press Releases
Sinovac Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Independent Special Committee
-
2016/01/28 | Press Releases
Sinovac Biotech Announces Issuance of GMP Certificate for EV71 Vaccine
-
2016/01/04 | Press Releases
Sinovac Obtains New Drug Certificate and Production License for EV71 Vaccine
-
2015/12/10 | Press Releases
Sinovac Obtains Clinical Trial Approval for Sabin-IPV Candidate
-
2015/11/12 | Press Releases
Sinovac Reports Unaudited Third Quarter Financial Results
-
2015/11/04 | Press Releases
Sinovac to Participate in Morgan Stanley Asia Pacific Summit
-
2015/11/02 | Press Releases
Sinovac to Host Conference Call to Report Third Quarter 2015 Unaudited Financial Results
-
2015/10/26 | Press Releases
Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate
-
2015/09/14 | Press Releases
Sinovac Receives Tender to Supply Seasonal Flu Vaccine in Beijing
-
2015/09/10 | Press Releases
Sinovac to Participate in Morgan Stanley Global Healthcare Conference
-
2015/08/13 | Press Releases
Sinovac Reports Unaudited Second Quarter Financial Results
BEIJING, Aug.12, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2015.
-
2015/08/11 | Press Releases
Sinovac Announces Results of 2015 Annual General Meeting of Shareholders
-
2015/08/04 | Press Releases
Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results
-
2015/07/08 | Press Releases
Sinovac Schedules 2015 Annual Meeting of Shareholders
-
2015/05/15 | Press Releases
Sinovac Reports Unaudited First Quarter 2015 Financial Results
-
2015/05/14 | Press Releases
Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities
-
2015/05/12 | Press Releases
Sinovac to Participate in UBS Global Healthcare Conference
-
2015/05/07 | Press Releases
Sinovac to Host Conference Call to Report First Quarter 2015 Unaudited Financial Results
-
2015/04/29 | Press Releases
Sinovac Files 2014 Annual Report on Form 20-F
-
2015/04/20 | Press Releases
Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results
-
2015/04/10 | Press Releases
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2014 Unaudited Financial Results
-
2015/03/18 | Press Releases
Sinovac to Participate in China Medical and Healthcare Investment Conference
-
2015/03/17 | Press Releases
Sinovac Provides Updates on Pipeline Vaccines
-
2014/11/15 | Press Releases
Sinovac Reports Unaudited Third Quarter Financial Results
-
2014/11/15 | Press Releases
Sinovac Reports Unaudited Third Quarter Financial Results
-
2014/11/05 | Press Releases
Sinovac to Host Conference Call to Report Third Quarter 2014 Unaudited Financial Results
-
2014/10/21 | Press Releases
Sinovac to Participate in Jefferies 4th Annual Asia Summit
-
2014/09/05 | Press Releases
Sinovac Announces New Presentation Time for Aegis Healthcare & Technology Conference
-
2014/09/02 | Press Releases
Sinovac to Participate in Upcoming Investor Conferences
-
2014/08/27 | Press Releases
Sinovac Announces Results of 2014 Annual General Meeting of Shareholders
-
2014/08/15 | Press Releases
Sinovac Reports Unaudited Second Quarter Financial Results
-
2014/07/25 | Press Releases
Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results
-
2014/07/23 | Press Releases
Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu
-
2014/07/21 | Press Releases
Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program
-
2014/07/14 | Press Releases
Sinovac Schedules 2014 Annual Meeting of Shareholders
-
2014/06/25 | Press Releases
Sinovac Announces Favorable Reduction in Value Added Tax Rate
-
2014/05/22 | Press Releases
Sinovac Reports Unaudited First Quarter 2014 Financial Results
-
2014/05/12 | Press Releases
Sinovac to Host Conference Call to Report First Quarter 2014 Unaudited Financial Results
-
2014/04/28 | Press Releases
Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV)
-
2014/04/24 | Press Releases
Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project
-
2014/04/16 | Press Releases
Sinovac Files 2013 Annual Report on Form 20-F
-
2014/03/20 | Press Releases
Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results
-
2014/03/12 | Press Releases
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 Unaudited Financial Results
-
2014/02/27 | Press Releases
Sinovac’s EV71 Vaccine Phase III Clinical Trial Results Published in New England Journal of Medicine
-
2014/01/29 | Press Releases
Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine against Avian Influenza A(H7N9) Virus
-
2014/01/22 | Press Releases
test
-
2013/11/13 | Press Releases
Sinovac Reports Unaudited Third Quarter 2013 Financial Results
-
2013/11/07 | Press Releases
Sinovac Receives Jiangsu Province Tender Award to Supply Inactivated Hepatitis Vaccine Healive® under Expanded Immunization Program
-
2013/11/04 | Press Releases
Sinovac to Host Conference Call to Report Third Quarter 2013 Unaudited Financial Results
-
2013/10/31 | Press Releases
Sinovac to participate in UBS Asia Healthcare CEO Summit in November 2013
-
2013/08/21 | Press Releases
Sinovac Holds 2013 Annual General Meeting of Shareholders
-
2013/08/14 | Press Releases
Sinovac Reports Unaudited Second Quarter 2013 Financial Results
-
2013/07/31 | Press Releases
Sinovac to Host Conference Call to Report Second Quarter 2013 Unaudited Financial Results
-
2013/07/19 | Press Releases
Sinovac Schedules 2013 Annual Meeting of Shareholders
-
2013/05/30 | Press Releases
Sinovac Files New Drug Application for EV71 Vaccine and Receives Filing Acceptance from Beijing Drug Administration
-
2013/05/28 | Press Releases
Sinovac Reports Unaudited First Quarter 2013 Financial Results
-
2013/05/24 | Press Releases
Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines
-
2013/05/17 | Press Releases
Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results
-
2013/05/15 | Press Releases
SINOVAC APPOINTS ERNST & YOUNG HUA MING LLP CHINA AS EXTERNAL AUDITOR
-
2013/05/14 | Press Releases
Sinovac Presents at the UBS Global Healthcare Conference in May 2013
-
2013/04/30 | Press Releases
Sinovac Files Annual Report on Form 20-F
-
2013/04/18 | Press Releases
Sinovac Reports Unaudited Fourth Quarter and Full Year 2012 Financial Results
-
2013/04/18 | Press Releases
Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
-
2013/04/18 | Press Releases
Sinovac Receives Commercial Approval in Mexico for Seasonal Flu Vaccine
-
2013/04/02 | Press Releases
Sinovac Schedules Conference Call and Webcast for Fourth Quarter and Full Year Unaudited Financial Results
-
2013/03/14 | Press Releases
Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease
-
2012/11/15 | Press Releases
Sinovac Reports Unaudited Third Quarter 2012 Financial Results
-
2012/10/29 | Press Releases
Sinovac to Host Conference Call to Report Third Quarter 2012 Unaudited Financial Results
-
2012/09/25 | Press Releases
Sinovac Awarded Tenders in Beijing and Shanghai to Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program
-
2012/09/18 | Press Releases
Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility
-
2012/09/10 | Press Releases
Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
-
2012/08/23 | Press Releases
Sinovac Holds 2012 Annual General Meeting of Shareholders
-
2012/08/15 | Press Releases
Sinovac Reports Unaudited Second Quarter 2012 Financial Results
-
2012/08/14 | Press Releases
TTTT
-
2012/08/06 | Press Releases
Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results
-
2012/07/16 | Press Releases
Sinovac Schedules 2012 Annual Meeting of Shareholders
sinovac
-
2012/06/26 | Press Releases
Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
-
2012/06/18 | Press Releases
Sinovac to Present at 5th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
-
2012/06/12 | Press Releases
Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial
-
2012/05/15 | Press Releases
Sinovac Reports Unaudited First Quarter 2012 Financial Results
-
2012/05/15 | Press Releases
Sinovac Names Danny Chung Chief Financial Officer
-
2012/05/08 | Press Releases
Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
-
2012/04/12 | Press Releases
Sinovac Participates in Goldman Sachs/Gao Hua Healthcare Corporate Day in Hong Kong
-
2012/04/12 | Press Releases
Sinovac Files Annual Report on Form 20-F
-
2012/03/29 | Press Releases
Sinovac Reports Unaudited Fourth Quarter and Preliminary Full Year 2011 Financial Results
-
2012/03/29 | Press Releases
Sinovac Announces Director Appointment
-
2012/03/29 | Press Releases
Sinovac's EV71 Vaccine Phase I Clinical Data for the Prevention of Epidemic Hand, Foot, Mouth Disease Published in Vaccine
-
2012/03/22 | Press Releases
Sinovac to Host Conference Call to Report Fourth Quarter 2011 Unaudited Financial Results
-
2012/01/24 | Press Releases
Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement
-
2012/01/10 | Press Releases
Sinovac Commences the Phase III Clinical Trial for its EV71 Vaccine Against Hand, Foot and Mouth Disease
-
2012/01/04 | Press Releases
Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
-
2011/11/14 | Press Releases
Sinovac Reports Unaudited Third Quarter 2011 Financial Results
-
2011/11/09 | Press Releases
Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
-
2011/11/08 | Press Releases
Sinovac to Host Conference Call to Report Third Quarter 2011 Unaudited Financial Results
-
2011/10/17 | Press Releases
Sinovac Selected by Beijing CDC to Supply Seasonal Influenza Vaccine Anflu(R) to Beijing Citizens
-
2011/09/27 | Press Releases
Sinovac's Animal Rabies Vaccine RabEnd Receives Production License
-
2011/08/12 | Press Releases
Sinovac Reports Unaudited Second Quarter 2011 Financial Results
-
2011/08/11 | Press Releases
Sinovac Receives GMP Certificate in Mexico for Seasonal Flu Vaccine and Hepatitis A Vaccine
Sinovac Receives GMP Certificate in Mexico for Seasonal Flu Vaccine and Hepatitis A Vaccine
-
2011/08/05 | Press Releases
Sinovac Announces Management Changes
-
2011/08/01 | Press Releases
Sinovac to Host Conference Call to Report Second Quarter 2011 Unaudited Financial Results
-
2011/07/15 | Press Releases
Sinovac Holds 2011 Annual Shareholders Meeting
-
2011/06/28 | Press Releases
Sinovac Commences Phase II Clinical Trial for EV71 Vaccine
-
2011/06/19 | Press Releases
Sinovac to Present at 5th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
-
2011/06/08 | Press Releases
Sinovac Schedules 2011 Annual Meeting of Shareholders
-
2011/05/31 | Press Releases
Sinovac Appoints Kenneth Lee to Board of Directors
-
2011/05/25 | Press Releases
Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
-
2011/05/13 | Press Releases
Sinovac Reports Unaudited First Quarter 2011 Financial Results
-
2011/05/10 | Press Releases
Sinovac Presents at Two Investor Conferences in May 2011
-
2011/05/04 | Press Releases
Sinovac to Host Conference Call to Report First Quarter 2011 Unaudited Financial Results
-
2011/04/23 | Press Releases
Sinovac Files Annual Report on Form 20-F
Sinovac
-
2011/03/31 | Press Releases
Sinovac Reports Fourth Quarter and Full Year 2010 Financial Results
-
2011/03/28 | Press Releases
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2010 Audited Financial Results
-
2011/03/25 | Press Releases
Sinovac Participates in UBS Greater China Healthcare Corporate Day
-
2011/03/10 | Press Releases
Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
-
2011/03/03 | Press Releases
Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
-
2011/03/01 | Press Releases
Sinovac Presents at Rodman & Renshaw Annual China Investment Conference
-
2011/01/31 | Press Releases
Sinovac Biotech Files Clinical Trial Applications with SFDA for its Proprietary Pneumococcal Polysaccharides Vaccines (PPV)
-
2011/01/31 | Press Releases
Sinovac Participates in UBS Greater China Conference 2011
-
2011/01/06 | Press Releases
Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
-
2010/12/28 | Press Releases
Sinovac Receives SFDA Approval to Commence Clinical Trials For Inactivated Enterovirus Type 71 Vaccine
-
2010/11/15 | Press Releases
Sinovac Reports Unaudited Third Quarter 2010 Financial Results
-
2010/11/01 | Press Releases
Sinovac to Host Conference Call to Report Third Quarter 2010 Unaudited Financial Results
-
2010/10/27 | Press Releases
Sinovac Participates in Two Investor Conferences in November
Sinovac Participates in Two Investor Conferences in November
-
2010/10/25 | Press Releases
Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
-
2010/10/25 | Press Releases
Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
-
2010/10/25 | Press Releases
Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
-
2010/08/16 | Press Releases
Sinovac Reports Unaudited Second Quarter 2010 Financial Results
-
2010/08/10 | Press Releases
Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results
-
2010/07/15 | Press Releases
Sinovac Holds 2010 Annual Meeting of Shareholders
-
2010/06/18 | Press Releases
Sinovac Schedules 2010 Annual Meeting of Shareholders
-
2010/06/01 | Press Releases
Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R)
-
2010/05/28 | Press Releases
Sinovac to Participate at 2010 Shanghai CPhI Exhibition
-
2010/05/24 | Press Releases
Sinovac to Present at 2010 UBS Global Specialty Pharmaceuticals Conference
-
2010/05/14 | Press Releases
Sinovac Reports Unaudited First Quarter 2010 Financial Results
-
2010/05/07 | Press Releases
Sinovac to Host Conference Call to Report First Quarter 2010 Financial Results
-
2010/05/06 | Press Releases
Sinovac Submits Clinical Trial Application for Mumps Vaccine to SFDA
-
2010/04/06 | Press Releases
Sinovac Reports Unaudited Fourth Quarter and Preliminary Full Year 2009 Record Financial Results
-
2010/03/30 | Press Releases
Sinovac to Host Conference Call to Report 2009 Fourth Quarter Financial Results
-
2010/03/30 | Press Releases
Sinovac Enters Exclusive Supply and Distribution Agreements with Parenteral Biotech Ltd. for India
-
2010/03/24 | Press Releases
Sinovac to Present at Inaugural China Healthcare Investment Conference
-
2010/02/24 | Press Releases
Sinovac Completes Acquisition Aimed at Expanding Production Capacity
-
2010/02/03 | Press Releases
Sinovac Announces Closing of Common Share Offering
-
2010/02/02 | Press Releases
Sinovac Announces Exercise of Over-Allotment Option
-
2010/01/28 | Press Releases
Sinovac Announces Upsizing and Pricing of Common Share Offering
-
2010/01/21 | Press Releases
Sinovac Announces Plan to Launch Offering of Common Shares
-
2010/01/21 | Press Releases
Sinovac Announces Recent Developments
-
2010/01/14 | Press Releases
/C O R R E C T I O N -- Sinovac Biotech Ltd.
-
2010/01/13 | Press Releases
Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
-
2009/12/28 | Press Releases
Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease
-
2009/12/28 | Press Releases
Sinovac's CEO Weidong Yin Presented with Annual Innovation Award by China Central Television
-
2009/12/22 | Press Releases
Sinovac Named One of China's Top 10 Most Competitive Companies Listed Overseas in 2009
-
2009/12/02 | Press Releases
Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government
-
2009/11/25 | Press Releases
Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities
-
2009/11/18 | Press Releases
Sinovac Files Shelf Registration Statement
-
2009/11/18 | Press Releases
Sinovac's PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric Population
-
2009/11/16 | Press Releases
Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive®
-
2009/11/16 | Press Releases
Sinovac Reports Unaudited Third Quarter 2009 Financial Results
-
2009/11/11 | Press Releases
Sinovac to Host Conference Call to Report 2009 Third Quarter Financial Results
-
2009/11/03 | Press Releases
Sinovac to Transfer Stock Exchange Listing to NASDAQ Global Market
-
2009/10/28 | Press Releases
Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
-
2009/10/22 | Press Releases
Sinovac Receives Certificate of Approval to Distribute PANFLU.1 (H1N1) in Mexico
-
2009/09/30 | Press Releases
Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government
-
2009/09/16 | Press Releases
Sinovac to Present at 2009 UBS Global Life Sciences Conference
-
2009/09/08 | Press Releases
Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
-
2009/09/08 | Press Releases
Hong Kong Department of Health Visited Sinovac on R&D and Production of H1N1 vaccine
-
2009/09/04 | Press Releases
Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government
-
2009/09/03 | Press Releases
Sinovac Obtains Production License for H1N1 Vaccine
-
2009/09/02 | Press Releases
Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea
-
2009/09/01 | Press Releases
Sinovac’s H1N1 Vaccine Passes Experts Evaluation Organized by SFDA
-
2009/08/31 | Press Releases
Sinovac Wins Beijing Public Health Bureau's Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
-
2009/08/19 | Press Releases
Sinovac Reports Top-Line Preliminary Results of H1N1 Vaccine Clinical Trials
-
2009/08/19 | Press Releases
Sinovac Reports Unaudited Second Quarter 2009 Financial Results
-
2009/08/12 | Press Releases
Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results
-
2009/08/04 | Press Releases
Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
-
2009/07/23 | Press Releases
Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
-
2009/07/09 | Press Releases
IP Biotech and Sinovac Enter Partnership Agreement
-
2009/07/01 | Press Releases
Sinovac Schedules 2008 Annual General Meeting
-
2009/07/01 | Press Releases
Sinovac Receives Revised Approvals for Panflu
-
2009/06/19 | Press Releases
Sinovac Receives China's First Influenza A (H1N1) Vaccine Order
-
2009/06/10 | Press Releases
Sinovac Begins the Production of Influenza A (H1N1) Vaccine
-
2009/06/03 | Press Releases
China's Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
-
2009/05/15 | Press Releases
Sinovac Reports Unaudited First Quarter 2009 Financial Results
-
2009/05/11 | Press Releases
Sinovac to Host Conference Call to Report First Quarter 2009 Financial Results
-
2009/05/02 | Press Releases
Sinovac Biotech Ltd. Files Annual Report on Form 20-F
-
2009/05/01 | Press Releases
Sinovac Receives RMB 87 Million Purchase Order for Healive from China
-
2009/04/30 | Press Releases
Sinovac Initiates Preparatory Activities for Swine Flu Vaccine
-
2009/04/27 | Press Releases
Beijing Mayor Visited Sinovac on Promoting Development of Biopharmaceutical Industry
-
2009/04/10 | Press Releases
CORRECTION-- Sinovac Biotech Ltd.
-
2009/04/09 | Press Releases
Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
-
2009/04/02 | Press Releases
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2008 Financial Results
-
2009/03/10 | Press Releases
Sinovac Biotech Co. Ltd., Sinovac's Beijing Subsidiary, Obtains High-Tech Enterprise Status
-
2009/03/03 | Press Releases
Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
-
2009/01/26 | Press Releases
Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
-
2009/01/03 | Press Releases
Sinovac Announces that Government Investigation Rules Out Healive
-
2008/12/22 | Press Releases
Sinovac Named to Zhongguancun's Top 20 Most Influential Brands
-
2008/12/03 | Press Releases
Sinovac Announces Share Repurchase Program
-
2008/12/03 | Press Releases
Sinovac Releases Statement on Healive Vaccine Suspension
-
2008/11/13 | Press Releases
Sinovac to Host Conference Call to Report Third Quarter 2008 Financial Results
-
2008/11/04 | Press Releases
Sinovac Named to Deloitte Technology Fast 50 China
-
2008/10/30 | Press Releases
Sinovac to Participate in Two Upcoming Investor Conferences
-
2008/10/10 | Press Releases
Sinovac's Credit Rating Upgraded to AAZ, Second Highest Rating
-
2008/09/26 | Press Releases
Sinovac to Present at the 2008 UBS Global Life Sciences Conference
-
2008/09/25 | Press Releases
Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
-
2008/09/23 | Press Releases
Sinovac Initiates Development of Vaccine Against Hand, Foot, and Mouth Disease
-
2008/09/22 | Press Releases
Sinovac Biotech Increases Ownership Position in its Operating Subsidiary Sinovac Beijing
-
2008/09/19 | Press Releases
Sinovac Biotech Holds 2007 Annual General Meeting
-
2008/09/16 | Press Releases
Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine
-
2008/09/11 | Press Releases
Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
-
2008/09/04 | Press Releases
Sinovac Adjourns Annual General Meeting
-
2008/09/02 | Press Releases
Sinovac to Present at the Susquehanna Financial Group's Second Annual Beijing Management Summit Conference
-
2008/08/15 | Press Releases
Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results
-
2008/08/12 | Press Releases
Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
-
2008/08/10 | Press Releases
Sinovac to Host Conference Call to Report Second Quarter 2008 Financial Results
-
2008/06/30 | Press Releases
Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
-
2008/06/17 | Press Releases
Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas
-
2008/06/12 | Press Releases
Sinovac Delivers 80,000 Doses of Bilive to Gansu Earthquake Disaster Area
-
2008/05/28 | Press Releases
Sinovac Receives RMB 20 Million Purchase Order for Healive from China's Ministry of Health to Vaccinate Earthquake Victims
-
2008/05/22 | Press Releases
Sinovac Provides Support to China's Ministry of Health to Aid Earthquake Victims
-
2008/05/16 | Press Releases
Sinovac Reports First Quarter 2008 Unaudited Financial Results
-
2008/05/16 | Press Releases
Sinovac to Host Conference Call to Report First Quarter 2008 Financial Results
-
2008/05/08 | Press Releases
Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
-
2008/04/10 | Press Releases
Sinovac Biotech Holds Annual General Meeting
-
2008/04/02 | Press Releases
Sinovac Receives SFDA's Approval for Pandemic Influenza H5N1 Vaccine
-
2008/04/01 | Press Releases
Sinovac Published Annual Report 2007 (20-F)
-
2008/03/31 | Press Releases
Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results
-
2008/03/26 | Press Releases
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results
-
2008/03/25 | Press Releases
Sinovac Announces Adjournment of Annual General Meeting
-
2008/03/25 | Press Releases
Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
-
2008/02/20 | Press Releases
Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
-
2008/02/04 | Press Releases
Sinovac Closes $9.75 Million Private Placement
-
2008/01/24 | Press Releases
Sinovac Announces $9.75 Million Private Placement
-
2007/12/26 | Press Releases
Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
-
2007/12/14 | Press Releases
Sinovac Requests Extension for Annual Shareholders Meeting
-
2007/12/14 | Press Releases
Sinovac's Hepatitis A Vaccine Healive Selected by Beijing Centers For Diseases Control and Prevention
-
2007/12/12 | Press Releases
Sinovac Reports Third Quarter 2007 Unaudited Financial Results
-
2007/11/21 | Press Releases
Sinovac Files Form 6-K with SEC
-
2007/11/21 | Press Releases
Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
-
2007/11/05 | Press Releases
Sinovac Enters Purchase Agreement with Beijing Public Health Bureau for Anflu, Sinovac's Seasonal Influenza Vaccine
-
2007/09/21 | Press Releases
Sinovac to Present at 2007 UBS Global Life Sciences Conference
-
2007/09/21 | Press Releases
Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
-
2007/09/21 | Press Releases
Sinovac Announces Postponement of Annual General Meeting
-
2007/08/16 | Press Releases
Sinovac Reports First Half 2007 Financial Results
-
2007/08/15 | Press Releases
Sinovac Commences Vaccination of Volunteers for the Clinical Research of Pandemic Influenza Vaccine (H5N1)
-
2007/08/14 | Press Releases
Sinovac Schedules First Half 2007 Financial Results Date
-
2007/08/02 | Press Releases
Sinovac Enters Exclusive Promotion Service Agreement with GlaxoSmithKline (China) Investment Co., Ltd.
-
2007/08/01 | Press Releases
Sinovac Schedules Annual General Meeting
-
2007/07/30 | Press Releases
Sinovac Receives Full Payment for Heping Wang's Obligations
-
2007/07/30 | Press Releases
Sinovac Issues Corporate Update
-
2007/05/10 | Press Releases
Sinovac Commences Phase II Clinical Trials for Pandemic Influenza Vaccine (H5N1)
-
2007/05/10 | Press Releases
Sinovac to Present at 2007 UBS Global Generic and Specialty Pharmaceuticals Conference
-
2007/05/10 | Press Releases
Sinovac Reports 2006 Financial Results
-
2007/05/10 | Press Releases
Sinovac Reports First Quarter 2007 Unaudited Sales
-
2007/04/10 | Press Releases
Sinovac Schedules 2006 Financial Results Date
-
2007/03/12 | Press Releases
Sinovac Provides Update on Study of Third Dose of Its Pandemic Influenza Vaccine
-
2007/03/02 | Press Releases
FIRST HUMAN CASE IN 2007 REPORTED
-
2007/02/09 | Press Releases
Sinovac Files Registration Documents for Euvax-B(TM) with SFDA Loan Repayment Received from One Former Director
-
2007/02/05 | Press Releases
Sinovac Schedules Investor Conference Call for February 6, 2007
-
2007/02/02 | Press Releases
Sinovac Clarifies Position on Restructuring Involving Its Chinese Subsidiary
-
2007/01/17 | Press Releases
Sinovac Reports Fourth Quarter 2006 Unaudited Sales and Provides Corporate Update for 2007
-
2006/11/29 | Press Releases
Sinovac Issues Corporate Update
-
2006/10/17 | Press Releases
Sinovac Biotech Ltd. Engages The Ruth Group as Investor Relations And Public Relations Counsel
-
2006/09/28 | Press Releases
Sinovac Biotech Ltd. Announces First Sales of its Seasonal Influenza Vaccine, Anflu(TM)
-
2006/09/13 | Press Releases
Sinovac Reports Semi-Annual Results
-
2006/09/08 | Press Releases
Sinovac Announces Its Clinical Trial Results of a Pandemic Influenza (H5N1) Vaccine Are Published by The Lancet
-
2006/08/29 | Press Releases
Preliminary Result of Phase I Clinical Trial Shows That Sinovac's Pandemic Influenza Vaccine (H5N1) has High Safety and Immunogenicity Profile
-
2006/08/03 | Press Releases
Sinovac Biotech Ltd. Changes Its Contact for Investor Relations
-
2006/07/20 | Press Releases
Ludlow Capital Adds Sinovac to China Small Cap Index
-
2006/07/15 | Press Releases
Sinovac Reports Fiscal 2005 Results
-
2006/07/03 | Press Releases
Sinovac Biotech Files Form 12b-25 with the U.S. Securities and Exchange Commission
-
2006/04/11 | Press Releases
Sinovac Completes Immunization Schedule in the Phase I Clinical Trial of its Proprietary Avian Influenza Vaccine (H5N1)
-
2006/03/14 | Press Releases
Sinovac Biotech Ltd., and LG Life Sciences, Ltd. Announce Distribution Agreement to Market Vaccines in the Peoples Republic of China
-
2006/02/28 | Press Releases
Sinovac Biotech Ltd. to Hold Annual Meeting of Stockholders and Business Objectives for 2006
-
2005/11/23 | Press Releases
Sinovac Receives Approval to Commence Human Clinical Trials for Pandemic Influenza Vaccine
-
2005/11/15 | Press Releases
Sinovac Passes China’s Ministry of Science and Technology “Pandemic Influenza Vaccine R&D Project” Examination
-
2005/10/27 | Press Releases
Sinovac Receives GMP Certification for its Seasonal Influenza Vaccine, AnFlu
-
2005/09/21 | Press Releases
Sinovac to present at the UBS Global Life Sciences Conference and Announces Additional Funding
-
2005/09/12 | Press Releases
Sinovac Biotech Ltd. Receives Flu Vaccine Production License from Chinese FDA
-
2005/09/12 | Press Releases
WHO Meeting Held to Review the Results of Sinovac SARS Vaccine Phase I Trial and Discuss Phase II Protocols
-
2005/09/12 | Press Releases
China’s new Vaccine Distribution System, and its Impact on Sinovac Biotech Ltd.
-
2005/09/12 | Press Releases
Sinovac Biotech Ltd. Announces First Sales of its Proprietary Combined Hepatitis A&B Vaccine, BiliveTM
-
2005/09/12 | Press Releases
Sinovac Biotech Ltd. Retains Segue Ventures, LLC for Investor Relations and Public Relations
-
2005/09/12 | Press Releases
SINOVAC BIOTECH LTD. REPORTS 2004 SALES GROWTH OF 127 %
-
2005/09/12 | Press Releases
Sinovac Biotech Ltd., and LG Life Sciences, Ltd. Announce their Letter of Intent for Collaboration in Global Marketing and Vaccine Supply
-
2005/09/12 | Press Releases
SINOVAC BIOTECH LTD. ANNOUNCES THAT IT HAS LAUNCHED THE MARKETING OF ITSPROPRIETARY COMBINED HEPATITIS A&B VACCINE, BILIVE™
-
2005/09/12 | Press Releases
SINOVAC BIOTECH LTD. ANOUNCES THAT IT HAS RECEIVED THE NEW DRUG CERTIFICATE FROM THE CHINESE GOVERNMENT FOR ITS SPLIT FLU VACCINE
-
2005/09/12 | Press Releases
Sinovac Biotech Ltd.: Updates on its Avian Influenza Vaccine Development
-
2005/09/12 | Press Releases
Sinovac Biotech Ltd. Announces Final Approval by the Chinese FDA (SFDA) for Bilive"TM", its Proprietary Combined Hepatitis A&B Vaccine
-
2005/09/12 | Press Releases
SINOVAC BIOTECH LTD. LISTED ON HALTER USX CHINA INDEX